Last updated on November 2019

An Investigational Immunotherapy Study of BMS-986310 Administered Alone and in Combination With Nivolumab in Patients With Advanced Solid Tumors

Brief description of study

The purpose of this study is to determine if BMS-986310 administered in combination with nivolumab, will demonstrate adequate safety and tolerability, as well as a favorable risk/benefit profile, to support further clinical testing.

Clinical Study Identifier: NCT03661632

Find a site near you

Start Over

Local Institution

Bruxelles, Belgium
  Connect »